Featured Research

from universities, journals, and other organizations

Sight gone, but not necessarily lost?

Date:
November 18, 2009
Source:
Johns Hopkins Medical Institutions
Summary:
Like all tissues in the body, the eye needs a healthy blood supply to function properly. Poorly developed blood vessels can lead to visual impairment or even blindness. While many of the molecules involved in guiding the development of the intricate blood vessel architecture are known, only now are we learning how these molecules work and how they might affect sight. Researchers have now found that when some cells in the mouse retina are not properly fed by blood vessels, they can remain alive for many months and can later recover some or all of their normal function, suggesting that similar conditions in people may also be reversible.

Like all tissues in the body, the eye needs a healthy blood supply to function properly. Poorly developed blood vessels can lead to visual impairment or even blindness. While many of the molecules involved in guiding the development of the intricate blood vessel architecture are known, only now are we learning how these molecules work and how they might affect sight.

Related Articles


Reporting in the Oct. 16 issue of Cell, researchers at the Johns Hopkins School of Medicine find that when some cells in the mouse retina are not properly fed by blood vessels, they can remain alive for many months and can later recover some or all of their normal function, suggesting that similar conditions in people may also be reversible.

"This finding is intriguing," says Jeremy Nathans, M.D., Ph.D., a professor of molecular biology and genetics, neuroscience and ophthalmology at Johns Hopkins and a Howard Hughes Medical Institute investigator. "It suggests that neurons in the retina can survive for an extended period of time even though they have been functionally silenced."

Three genes -- named Fz4, Ndp and Lrp5 -- previously were suspected to be involved in blood vessel development in the human retina. Defects in any of these genes cause hypovascularization -- a lack of sufficient blood vessels -- in the retina. Similarly, eliminating any of these genes in mice can lead to hypovascularized retinas.

Mice lacking functional Fz4 have poor blood vessel growth in the retina and are blind, but it was not known whether the blood vessel deficiency was the cause of blindness or whether the absence of Fz4 leads to some other defect that causes blindness. The team found that Fz4 function is required only in blood vessels, where it senses a signal produced by the Ndp gene in other retinal cells.

When the team measured electrical responses in retinal cells of mice lacking Fz4, they found a defect in electrical signaling in the middle layer of the retina -- the same region lacking blood vessels.

The researchers then bathed the Fz4 mutant retinas in oxygen and nutrients to mimic a normal blood supply, and measured electrical signaling in response to light. They found that when provided with oxygen and nutrients, the retinas were able to sense light and generate signals similar to those generated by normal retinas. The team suggests that in the absence of Fz4 the defective blood vessels provide the retinas with only enough oxygen and nutrients to keep the retinal cells alive, but not enough for them to function normally to send electrical signals.

"If the human retina responds to a decrease in blood supply in the same way that the mouse retina responds, then these results may have relevance for those patients with vision loss due to vascular defects," says Nathans.

"In particular, these experiments suggest that if a region of the retina has been deprived of its normal blood supply, then completely or partially restoring that supply may also restore some visual function, even if this happens weeks or months later."

This study was funded by the National Eye Institute and the Howard Hughes Medical Institute.

Authors on the paper are Yin Ye, Yanshu Wang, Hugh Cahill, Tudor Badea, Philip Smallwood and Nathans of Johns Hopkins, and Minzhong Yu and Neal Peachey of the Cole Eye Institute, Cleveland Clinic Foundation.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Sight gone, but not necessarily lost?." ScienceDaily. ScienceDaily, 18 November 2009. <www.sciencedaily.com/releases/2009/10/091031002323.htm>.
Johns Hopkins Medical Institutions. (2009, November 18). Sight gone, but not necessarily lost?. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2009/10/091031002323.htm
Johns Hopkins Medical Institutions. "Sight gone, but not necessarily lost?." ScienceDaily. www.sciencedaily.com/releases/2009/10/091031002323.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins